Matches in Wikidata for { <http://www.wikidata.org/entity/Q92532201> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q92532201 description "2020 թվականի հունվարի 10-ին հրատարակված գիտական հոդված" @default.
- Q92532201 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92532201 description "scientific article published on 10 January 2020" @default.
- Q92532201 description "wetenschappelijk artikel" @default.
- Q92532201 description "наукова стаття, опублікована 10 січня 2020" @default.
- Q92532201 name "Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma" @default.
- Q92532201 name "Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma" @default.
- Q92532201 type Item @default.
- Q92532201 label "Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma" @default.
- Q92532201 label "Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma" @default.
- Q92532201 prefLabel "Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma" @default.
- Q92532201 prefLabel "Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma" @default.
- Q92532201 P1433 Q92532201-38EADC77-8469-4C43-94BD-4FE4EAFAB1D6 @default.
- Q92532201 P1476 Q92532201-04179901-25CD-4D70-B396-AECFFA47B046 @default.
- Q92532201 P2093 Q92532201-2148C8F7-717F-4F52-A972-005CB743B956 @default.
- Q92532201 P2093 Q92532201-33B3B206-1739-4837-BABB-B7CC8F2947DD @default.
- Q92532201 P2093 Q92532201-4AE70BDC-A1FA-4E26-9F19-133E694AF826 @default.
- Q92532201 P2093 Q92532201-57F7E2F0-9C3A-4492-8D72-D3D437B89F8C @default.
- Q92532201 P2093 Q92532201-9B7D6B5F-0AD2-458F-AA6B-91A24D2914D7 @default.
- Q92532201 P2093 Q92532201-9F5479FE-7767-474B-9366-65BCB2C996FD @default.
- Q92532201 P304 Q92532201-0D7B57BD-AD78-43B6-BA6C-1E79B867CDAA @default.
- Q92532201 P31 Q92532201-51F0C0E5-954C-4051-A7B7-3E01683A9010 @default.
- Q92532201 P356 Q92532201-EF86887A-61E9-4859-A6FC-3C99ECFA8307 @default.
- Q92532201 P433 Q92532201-7CDA537E-F11B-4B8A-A07F-95DED969F929 @default.
- Q92532201 P478 Q92532201-7130E0F3-FD67-41E3-AFCC-39EEE1A40493 @default.
- Q92532201 P577 Q92532201-94B7B27E-0ACF-4634-B8C1-472653CB6A5A @default.
- Q92532201 P698 Q92532201-2A9CC7D6-1A45-4287-A06D-86FD373D6ADF @default.
- Q92532201 P921 Q92532201-4ABC08D8-B33E-4EBB-B7C2-86BB31C4443B @default.
- Q92532201 P921 Q92532201-CA41D905-9EF8-4A24-95EF-BFFB16AD04FB @default.
- Q92532201 P356 0284186X.2020.1712473 @default.
- Q92532201 P698 31920132 @default.
- Q92532201 P1433 Q326164 @default.
- Q92532201 P1476 "Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma" @default.
- Q92532201 P2093 "Guo Wei" @default.
- Q92532201 P2093 "John R Hyngstrom" @default.
- Q92532201 P2093 "Justin C Moser" @default.
- Q92532201 P2093 "Kenneth F Grossmann" @default.
- Q92532201 P2093 "Sarah V Colonna" @default.
- Q92532201 P2093 "Shiven Patel" @default.
- Q92532201 P304 "434-437" @default.
- Q92532201 P31 Q13442814 @default.
- Q92532201 P356 "10.1080/0284186X.2020.1712473" @default.
- Q92532201 P433 "4" @default.
- Q92532201 P478 "59" @default.
- Q92532201 P577 "2020-01-10T00:00:00Z" @default.
- Q92532201 P698 "31920132" @default.
- Q92532201 P921 Q13896859 @default.
- Q92532201 P921 Q18975855 @default.